EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Impact of nicotine concentration, form, and stereoisomer ratio on oral nicotine pouch pharmacokinetics and abuse liability: Protocol for a randomized crossover study in adults who use tobacco

Patrick M Tomko iD, Yoo Jin Cho iD, Hayley Curran, Alice Hinton, Theodore L Wagener, Marielle C Brinkman iD, Brittney Keller-Hamilton iD

PLOS One · 16.11.2026 · 21 (11) · e0362198

DOI: 10.1371/journal.pone.0362198 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, online erschienen am 16.11.2026. Verfasst von Patrick M Tomko und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of Ameri…. Hauptthemen laut MEDLINE: Nicotine. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDA NIH HHS, Division of Cancer Prevention, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Oral nicotine pouches (ONPs) are tobacco-free products placed between the lip and gum to deliver nicotine. Sales have grown rapidly in the United States (U.S.), yet independent data on how nicotine characteristics shape ONP appeal and addiction potential are lacking. Three nicotine characteristics vary across ONPs: concentration (mass of nicotine per pouch), form (the fraction of freebase, or unprotonated, nicotine), and stereoisomer (the proportion of S- to R-nicotine). This study will determine how these characteristics independently and jointly affect ONP nicotine pharmacokinetics and user experience among adults who smoke cigarettes or use moist snuff . Design and participants This randomized, double-blind, crossover trial will enroll 160 adults who smoke cigarettes or use moist snuff at a single U.S. site. Interventions and outcomes Participants will be randomized 1:1 to a lower (3 mg) or higher (6 mg) nicotine concentration arm. Within each arm, participants will complete five laboratory sessions in balanced, randomized order: four standardized ONP sessions (30 minutes, with the pouch placed between lip and gum) varying by nicotine form (30% vs. 70% freebase) and stereoisomer ratio (racemic [50% R- and 50% S-nicotine] vs. > 99% S-nicotine), plus one session using their usual tobacco product. Sessions will be separated by at least 48 hours. The primary outcome is maximum plasma nicotine concentration (Cmax). Secondary outcomes include time to maximum concentration (Tmax), total nicotine absorbed over 90 minutes (AUC), subjective effects, and behavioral economic demand indices.

Conclusions

This will be the first study to systematically examine how nicotine concentration, form, and stereoisomer ratio interact to influence ONP abuse liability. Findings will identify which product characteristics drive ONP addiction potential and will inform FDA regulation aimed at maximizing the potential for ONPs to serve as a harm reduction alternative to cigarettes and moist snuff.

Trial registration

ClinicalTrials.gov NCT06315881 ; registered February 14, 2024.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NicotineHumansCross-Over StudiesDouble-Blind MethodStereoisomerismRandomized Controlled Trials as TopicAdultAdministration, OralFemaleTobacco Use Disorder

Substanzen

Nicotine

Autor:innen und Institutionen

  • Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.
  • Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.
  • Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio, United States of America.

ORCID-Profile: Patrick M Tomko, Yoo Jin Cho, Marielle C Brinkman, Brittney Keller-Hamilton

Förderung

  • NCI NIH HHS
  • NIDA NIH HHS
  • Division of Cancer Prevention, National Cancer Institute
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute

Zitieren

APA

Tomko, P. M., Cho, Y. J., Curran, H., Hinton, A., Wagener, T. L., Brinkman, M. C., & Keller-Hamilton, B. (2026). Impact of nicotine concentration, form, and stereoisomer ratio on oral nicotine pouch pharmacokinetics and abuse liability: Protocol for a randomized crossover study in adults who use tobacco. PLOS One, 21(11), e0362198. https://doi.org/10.1371/journal.pone.0362198

Vancouver

Tomko PM, Cho YJ, Curran H, Hinton A, Wagener TL, Brinkman MC, et al. Impact of nicotine concentration, form, and stereoisomer ratio on oral nicotine pouch pharmacokinetics and abuse liability: Protocol for a randomized crossover study in adults who use tobacco. PLOS One. 2026;21(11):e0362198. doi:10.1371/journal.pone.0362198

BibTeX
@article{Tomko2026,
  author = {Tomko, Patrick M and Cho, Yoo Jin and Curran, Hayley and Hinton, Alice and Wagener, Theodore L and Brinkman, Marielle C and Keller-Hamilton, Brittney},
  title = {Impact of nicotine concentration, form, and stereoisomer ratio on oral nicotine pouch pharmacokinetics and abuse liability: Protocol for a randomized crossover study in adults who use tobacco},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0362198},
  doi = {10.1371/journal.pone.0362198}
}
Kostenlos starten →